thymosin-beta(4) and Carcinoma

thymosin-beta(4) has been researched along with Carcinoma* in 3 studies

Other Studies

3 other study(ies) available for thymosin-beta(4) and Carcinoma

ArticleYear
Subcellular distribution of thymosin beta4.
    Annals of the New York Academy of Sciences, 2007, Volume: 1112

    The localization of Oregon Green cadaverine-labeled thymosin beta(4), its fragments, and variants was investigated in cytoplasm-depleted A431 cells and in microinjected cells without and with fixation. The studied thymosin beta(4) variants included substitutions of the lysine residues within the basic cluster (14-KSKLKK-19) and the actin-binding motif (17-LKKTETQ-23). In contrast to Oregon Green cadaverine, none of the variants or fragments of thymosin beta(4) could pass the intact nuclear pore of cytoplasm-depleted cells and were hence excluded from the nucleus. However, an equal distribution of all thymosin beta(4) variants was observed in living cells. The nuclear localization is neither dependent on the actin-binding ability of thymosin beta(4) nor on its basic lysine cluster. The equal distribution of the beta-thymosins, the ability of the fragments thymosin beta(4)(1-26) and beta(4)(27-43) to enter the nucleus in intact cells immediately after injection, and their exclusion from cytoplasm-depleted nuclei make it unlikely that they are transported by a single transport protein. A passive but regulated diffusion could explain the described ability of thymosin beta(4) to shuttle into the nucleus.

    Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Carcinoma; Cell Line, Tumor; Genetic Variation; Humans; Microscopy, Confocal; Molecular Sequence Data; Recombinant Proteins; Spleen; Subcellular Fractions; Swine; Thymosin

2007
Overexpression of the thymosin beta-4 gene is associated with malignant progression of SW480 colon cancer cells.
    Oncogene, 2003, May-22, Volume: 22, Issue:21

    Thymosin beta-4 (Tbeta-4), a small peptide originally isolated from calf thymus, modulates the formation of F-actin microfilaments by sequestering the monomeric G-actin. Recent studies have shown that overexpression of the Tbeta-4 gene occurs not only in many human carcinomas but also in the highly metastatic melanomas and fibrosarcomas. However, little is known about the specific growth advantages acquired by different tumors from this genetic abnormality. To address the above questions, Tbeta-4-overexpressing human colon carcinoma (SW480) cells were established by stable transfection and their phenotypic changes were monitored. We found that both the morphology and the cortical actin cytoskeleton of SW480 cells were altered by Tbeta-4 overexpression. Moreover, both cellular level and that distributed over the intercellular junctions of the E-cadherin were decreased in the Tbeta-4 overexpressers, which were accompanied by a twofold increase in their saturation densities. Meanwhile, these cells also exhibited an increased ability to form colonies in soft agar. Interestingly, a dramatic increase of growth rate was detected in the Tbeta-4 overexpressers, which might be attributed to an accelerated proliferation induced by c-Myc that was activated by nuclear beta-catenin. Finally, a motility increase of these cells was demonstrated by two independent migration assays, which was accompanied by an enhanced focal contact. Taken together, our data suggest that the drastic growth property and motility changes of the SW480 cells overexpressing Tbeta-4 gene are due mainly to a deregulated cell-cell adhesion arisen from the downregulation of E-cadherin, plus uncontrolled cell proliferation owing to the upregulation of beta-catenin, both resulted from a breakdown of actin microfilaments caused by the overexpression of this G-actin sequestering peptide.

    Topics: beta Catenin; Cadherins; Carcinoma; Cell Division; Cell Movement; Colonic Neoplasms; Cytoskeletal Proteins; Disease Progression; Focal Adhesions; Humans; Proto-Oncogene Proteins c-myc; Thymosin; Trans-Activators; Transfection; Tumor Cells, Cultured; Tumor Stem Cell Assay

2003
Isolation and structural characterization of thymosin-beta 4 from a human medullary thyroid carcinoma.
    The Journal of endocrinology, 1988, Volume: 118, Issue:1

    An extract of a tumour metastases from a human medullary thyroid carcinoma contained a high concentration (at least 2.9 nmol/g wet weight) of the immunoregulatory peptide, thymosin-beta 4. The peptide was isolated as a mixture of two components with free and blocked NH2-terminal amino acid residues, the latter form predominating (approximately 98% of the total). The primary structure of the peptide was established by automated Edman degradation after cleavage with cyanogen bromide. The amino acid sequence of human thymosin-beta 4 was identical to thymosin-beta 4 previously isolated from calf thymus. Further studies are warranted to determine whether thymosin-beta 4 production is a useful marker for thyroid and other tumours.

    Topics: Adult; Carcinoma; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Humans; Male; Thymosin; Thyroid Neoplasms

1988